Explain this page
Arphra AIPlain-English read on Relay Therapeutics, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $24.00 (+51.13%)
Candlestick · 1Y
Open in chart workstation →RLAY
15.88+94.85%H 17.47L 7.60MA50 12.31MA200 —Avg vol 3.5M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.06% | +5.59% | +21.97% | +60.24% | +89.05% | +87.71% | +397.81% | +31.02% | -55.05% | -54.69% | -54.69% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$16.10
59 sh
Bid
$14.90
100 sh
Ask
$16.43
1 sh
Spread
$1.530
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Peers
No peer list available for RLAY.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|